Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy

摘要

This is the largest study to date evaluating response rates and pathologic complete response (pCR) and predictors thereof, based on molecular subtype, in women with breast cancer having undergone neoadjuvant chemotherapy (NC).